OrbiMed’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.83M | Hold |
|
|||||
|
2025
Q1 | $8.38M | Hold |
|
|||||
|
2024
Q4 | $13.9M | Hold |
|
|||||
|
2024
Q3 | $22.6M | Hold |
|
|||||
|
2024
Q2 | $41.6M | Hold |
|
|||||
|
2024
Q1 | $51.7M | Hold |
|
|||||
|
2023
Q4 | $46.6M | Hold |
|
|||||
|
2023
Q3 | $33.7M | Hold |
|
|||||
|
2023
Q2 | $49.1M | Buy |
|
|||||
|
2023
Q1 | $57.2M | Hold |
|
|||||
|
2022
Q4 | $60.6M | Hold |
|
|||||
|
2022
Q3 | $66.4K | Hold |
|
|||||
|
2022
Q2 | $52.4K | Hold |
|
|||||
|
2022
Q1 | $69.3M | Hold |
|
|||||
|
2021
Q4 | $125M | Hold |
|
|||||
|
2021
Q3 | $314M | Hold |
|
|||||
|
2021
Q2 | $287M | Hold |
|
|||||
|
2021
Q1 | $435M | Sell |
|
|||||
|
2020
Q4 | $1.12B | Hold |
|
|||||
|
2020
Q3 | $470M | Buy |
|